Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
Wallace, Christopher G
JournalClinical and Developmental Immunology
Research Support, Non-U.S. Gov't
RightsArchived with thanks to Clinical and Developmental Immunology
MetadataShow full item record
Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and VCA rejection.